166 related articles for article (PubMed ID: 27372966)
1. BIRC5 Genomic Copy Number Variation in Early-Onset Breast Cancer.
Ghaffari K; Hashemi M; Ebrahimi E; Shirkoohi R
Iran Biomed J; 2016 Sep; 20(4):241-5. PubMed ID: 27372966
[TBL] [Abstract][Full Text] [Related]
2. Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis.
Dai JB; Zhu B; Lin WJ; Gao HY; Dai H; Zheng L; Shi WH; Chen WX
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043523
[TBL] [Abstract][Full Text] [Related]
3. BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy.
Hamy AS; Bieche I; Lehmann-Che J; Scott V; Bertheau P; Guinebretière JM; Matthieu MC; Sigal-Zafrani B; Tembo O; Marty M; Asselain B; Spyratos F; de Cremoux P
Breast Cancer Res Treat; 2016 Oct; 159(3):499-511. PubMed ID: 27592112
[TBL] [Abstract][Full Text] [Related]
4. [Expression of the antiapoptotic protein survinin and its gene in primary breast carcinoma].
Shlyakhtunov YA; Klopova VA
Arkh Patol; 2019; 81(2):18-23. PubMed ID: 31006775
[TBL] [Abstract][Full Text] [Related]
5. Significance of Serum Survivin and -31G/C Gene Polymorphism in the Early Diagnosis of Breast Cancer in Egypt.
Motawi TMK; Zakhary NI; Darwish HA; Abdalla HM; Tadros SA
Clin Breast Cancer; 2019 Apr; 19(2):e276-e282. PubMed ID: 30765238
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional expression analysis of survivin splice variants reveals differential expression of survivin-3α in breast cancer.
Moniri Javadhesari S; Gharechahi J; Hosseinpour Feizi MA; Montazeri V; Halimi M
Genet Test Mol Biomarkers; 2013 Apr; 17(4):314-20. PubMed ID: 23368531
[TBL] [Abstract][Full Text] [Related]
7. Survivin in Breast Cancer: A Review.
Martínez-Sifuentes MA; Bassol-Mayagoitia S; Nava-Hernández MP; Ruiz-Flores P; Ramos-Treviño J; Haro-Santa Cruz J; Hernández-Ibarra JA
Genet Test Mol Biomarkers; 2022 Sep; 26(9):411-421. PubMed ID: 36166738
[TBL] [Abstract][Full Text] [Related]
8. miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells.
Yang R; Liu M; Liang H; Guo S; Guo X; Yuan M; Lian H; Yan X; Zhang S; Chen X; Fang F; Guo H; Zhang C
Mol Cancer; 2016 Dec; 15(1):82. PubMed ID: 27978829
[TBL] [Abstract][Full Text] [Related]
9. Copy number profiling of Oncotype DX genes reveals association with survival of breast cancer patients.
Ahmed W; Malik MFA; Saeed M; Haq F
Mol Biol Rep; 2018 Dec; 45(6):2185-2192. PubMed ID: 30225582
[TBL] [Abstract][Full Text] [Related]
10. Improved Multiplex Ligation-dependent Probe Amplification (i-MLPA) for rapid copy number variant (CNV) detection.
Saxena S; Gowdhaman K; Kkani P; Vennapusa B; Rama Subramanian C; Ganesh Kumar S; Mohan KN
Clin Chim Acta; 2015 Oct; 450():19-24. PubMed ID: 26234520
[TBL] [Abstract][Full Text] [Related]
11. Detection of RB1 Gene Copy Number Variations Using a Multiplex Ligation-Dependent Probe Amplification Method.
Dalay N
Methods Mol Biol; 2018; 1726():7-18. PubMed ID: 29468539
[TBL] [Abstract][Full Text] [Related]
12. Stuffer-free multiplex ligation-dependent probe amplification based on conformation-sensitive capillary electrophoresis: a novel technology for robust multiplex determination of copy number variation.
Shin GW; Jung SH; Yim SH; Chung B; Yeol Jung G; Chung YJ
Electrophoresis; 2012 Oct; 33(19-20):3052-61. PubMed ID: 22965760
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of Baculoviral Inhibitor of Apoptosis Repeat-Containing 5 (BIRC5) Can Be Associated with Clinical Outcome of Non-Small Cell Lung Cancer.
Szczyrek M; Mlak R; Szudy-Szczyrek A; Wojas-Krawczyk K; Kędziora K; Milanowski J
Cells; 2022 Mar; 11(6):. PubMed ID: 35326407
[TBL] [Abstract][Full Text] [Related]
14. Multiplex PCB-based electrochemical detection of cancer biomarkers using MLPA-barcode approach.
Sánchez JL; Henry OY; Joda H; Solnestam BW; Kvastad L; Johansson E; Akan P; Lundeberg J; Lladach N; Ramakrishnan D; Riley I; O'Sullivan CK
Biosens Bioelectron; 2016 Aug; 82():224-32. PubMed ID: 27085955
[TBL] [Abstract][Full Text] [Related]
15. Pan-cancer analysis identifies BIRC5 as a prognostic biomarker.
Fäldt Beding A; Larsson P; Helou K; Einbeigi Z; Parris TZ
BMC Cancer; 2022 Mar; 22(1):322. PubMed ID: 35331169
[TBL] [Abstract][Full Text] [Related]
16. The expression of BIRC5 is correlated with loss of specific chromosomal regions in breast carcinomas.
Boidot R; Vegran F; Jacob D; Chevrier S; Gangneux N; Taboureau J; Oudin C; Rainville V; Mercier L; Lizard-Nacol S
Genes Chromosomes Cancer; 2008 Apr; 47(4):299-308. PubMed ID: 18181175
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in Survivin (
Sušac I; Ozretić P; Gregorić M; Levačić Cvok M; Sabol M; Levanat S; Trnski D; Eljuga D; Seiwerth S; Aralica G; Stanec M; Musani V
J Oncol; 2019; 2019():3483192. PubMed ID: 31467536
[TBL] [Abstract][Full Text] [Related]
18. A modified multiplex ligation-dependent probe amplification method for the detection of 22q11.2 copy number variations in patients with congenital heart disease.
Zhang X; Xu Y; Liu D; Geng J; Chen S; Jiang Z; Fu Q; Sun K
BMC Genomics; 2015 May; 16(1):364. PubMed ID: 25952753
[TBL] [Abstract][Full Text] [Related]
19. [Numerical impairments in genes in breast cancer: a multiplex ligation-dependent probe amplification study].
Matsionis AE; Petrov AV; Gorelik MZ; Zavalishina LE
Arkh Patol; 2014; 76(4):15-7. PubMed ID: 25306619
[TBL] [Abstract][Full Text] [Related]
20. Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer.
Wang H; Zhang X; Wang L; Zheng G; Du L; Yang Y; Dong Z; Liu Y; Qu A; Wang C
J Surg Oncol; 2014 May; 109(6):574-9. PubMed ID: 24338523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
